Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Opsens - Robin Villeneuve Appointed as Chief Financial Officer

Canada NewsWire

QUEBEC CITY, June 7, 2017 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) today announces that to support its growth phase and positioning in the medical market, the Company recruited Robin Villeneuve as Chief Financial Officer. This appointment enters into force immediately.

Mr. Villeneuve recently worked as Chief Financial Officer of Federal Fleet Services Inc., a private maritime company. Previously, he was Chief Financial Officer of Virginia Mines Inc. from 2008 until its acquisition in 2015. Prior to that, he worked in several strategic financial positions for AbitibiBowater Inc., now known as Produits Forestiers Résolu Inc.

"I am very enthusiastic to join Opsens as the Company intensifies its commercial activities," said Mr. Villeneuve.

"Mr. Villeneuve's experience will be beneficial in implementing Opsens' financial strategy. We are very pleased to see him join us," added Louis Laflamme, President and Chief Executive Officer of Opsens.

About Opsens Inc. ( www.opsens.com or www.opsensmedical.com )

Opsens focuses mainly on the measure of FFR in interventional cardiology. Opsens offers an advanced optical-based pressure guidewire (OptoWire) that aims at improving the clinical outcome of patients with coronary artery disease. Opsens is also involved in industrial activities, offering solutions for critical applications, such as the monitoring of oil wells and other demanding industrial applications.

Forward-looking statements contained in this press release involve known and unknown risks, uncertainties and other factors that may cause actual results, performance and achievements of Opsens to be materially different from any future results, performance or achievements expressed or implied by the said forward-looking statements.

Neither the TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.

 

SOURCE OPSENS INC.

View original content: http://www.newswire.ca/en/releases/archive/June2017/07/c1551.html



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today